Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
February 15 2024 - 4:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced that it plans to release
its fourth quarter and full year 2023 financial results after
market close on Thursday, February 29, 2024.
Management will hold a conference call to review the Company’s
fourth quarter and full year 2023 performance starting at 4:30 p.m.
(Eastern Time) on the same day. The conference call will be
concurrently webcast. The link to the webcast will be available on
Senseonics Holdings, Inc. website at www.senseonics.com by
navigating to “Investor Relations,” and then “Events &
Publications,” and will be archived there for future reference. To
listen to the conference call, please dial 1-888-317-6003
(US/Canada) or 1-412-317-6061 (International), passcode 3711982,
approximately ten to five minutes prior to start time.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology
company focused on the development and manufacturing of glucose
monitoring products designed to transform lives in the global
diabetes community with differentiated, long-term implantable
glucose management technology. Senseonics’ CGM system Eversense® E3
includes a small sensor inserted completely under the skin that
communicates with a smart transmitter worn over the sensor. The
glucose data are automatically sent every 5 minutes to a mobile app
on the user’s smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240215367533/en/
Investor Contact Philip Taylor Gilmartin Group
415-937-5406 Investors@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From May 2024 to Jun 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
From Jun 2023 to Jun 2024